Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals
- 1 August 2008
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (22) , 3721-3726
Abstract
Purpose Several publications showed that the standards for reporting randomized clinical trials (RCTs) might not be entirely suitable. Our aim was to evaluate the reporting of survival end points in cancer RCTs. Methods A search in MEDLINE databases identified 274 cancer RCTs published in 2004 in four general medical journals and four clinical oncology journals. Eligible articles were those that reported primary analyses of RCT with survival end points. Methodologists reviewed and scored the articles according to seven key points: prevalence of complete definition of survival end points (time of origin, survival events, censoring events) and relevant information about their analyses (estimation or effect size, precision, number of events, patients at risk). Concordance of key points was evaluated from a random subsample. Results After screening, 125 articles were selected; 104 trials were phase III (83%) and 98 publications (78%) were obtained from oncology journals. Among these RCTs, a total of 267 survival end points were recorded, and overall survival (OS) was the most frequent outcome (118 terms, 44%). Survival terms were totally defined for 113 end points (42%) in 65 articles (52%). Accurate information about analysis was retrieved for 73 end points (27%) in 40 articles (32%). The less well-defined information was the number of patients at risk (55%). The reliability was good (κ = 0.72). Finally, according to the key points, optimal reporting was found in 33 end points (12%) or 10 publications. Conclusion A majority of articles failed to provide a complete reporting of survival end points, thus adding another source of uncontrolled variability.Keywords
This publication has 21 references indexed in Scilit:
- Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future TrialsJNCI: Journal of the National Cancer Institute, 2007
- Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP SystemJournal of Clinical Oncology, 2007
- Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authorsBMJ, 2005
- Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journalsBMJ, 2005
- Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authorsBMJ, 2005
- Survival Analysis Part I: Basic concepts and first analysesBritish Journal of Cancer, 2003
- Use of the CONSORT Statement and Quality of Reports of Randomized TrialsJAMA, 2001
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Review of survival analyses published in cancer journalsBritish Journal of Cancer, 1995
- Reporting on Methods in Clinical TrialsNew England Journal of Medicine, 1982